Inflammatory bowel disease extending its reach

Gastroenterology

Volumn 129, Issue 3, 2005, Pages 1117-1120

  Loftus Jr , Edward V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INFLIXIMAB; LENERCEPT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NATALIZUMAB; SALAZOSULFAPYRIDINE;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CROHN DISEASE; DATA BASE; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; EDITORIAL; ENTERITIS; EPIDEMIOLOGICAL DATA; HUMAN; LUNG DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK ASSESSMENT; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 24144487046     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.07.042     Document Type: Editorial

References (38)

1. C.N. Bernstein, A. Wajda, J.F. Blanchard The clustering of other chronic inflammatory diseases in inflammatory bowel disease a population-based study Gastroenterology 129 2005 827 836
2. G. Gupta, J.M. Gelfand, J.D. Lewis Increased risk of demyelinating diseases in patients with inflammatory bowel disease Gastroenterology 129 2005 819 826
3. C.N. Bernstein, J.F. Blanchard, P. Rawsthorne, A. Wajda Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province a population-based study Am J Epidemiol 149 1999 916 924
4. C.N. Bernstein, J.F. Blanchard, P. Rawsthorne, N. Yu The prevalence of extraintestinal diseases in inflammatory bowel disease a population-based study Am J Gastroenterol 96 2001 1116 1122
5. C.N. Bernstein, J.F. Blanchard, E. Kliewer, A. Wajda Cancer risk in patients with inflammatory bowel disease a population-based study Cancer 91 2001 854 862
6. C.N. Bernstein, J.F. Blanchard, W. Leslie, A. Wajda, B.N. Yu The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study Ann Intern Med 133 2000 795 799
7. C.N. Bernstein, J.F. Blanchard, D.S. Houston, A. Wajda The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease a population-based cohort study Thromb Haemost 85 2001 430 434
8. J.D. Lewis, C. Brensinger, W.B. Bilker, B.L. Strom Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease Pharmacoepidemiol Drug Safety 11 2002 211 218
9. J.D. Lewis, W.B. Bilker, C. Brensinger, J.J. Deren, D.J. Vaughn, B.L. Strom Inflammatory bowel disease is not associated with an increased risk of lymphoma Gastroenterology 121 2001 1080 1087
10. J.D. Lewis, F.N. Aberra, G.R. Lichtenstein, W.B. Bilker, C. Brensinger, B.L. Strom Seasonal variation in flares of inflammatory bowel disease Gastroenterology 126 2004 665 673
11. F.N. Aberra, C.M. Brensinger, W.B. Bilker, G.R. Lichtenstein, J.D. Lewis Antibiotic use and the risk of flare of inflammatory bowel diseas Clin Gastroenterol Hepatol 3 2005 459 465
12. T. Card, R. Hubbard, R.F. Logan Mortality in inflammatory bowel disease a population-based cohort study Gastroenterology 125 2003 1583 1590
13. T. Card, J. West, R. Hubbard, R.F. Logan Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use a population based cohort study Gut 53 2004 251 255
14. T.P. Van Staa, S. Travis, H.G. Leufkens, R.F. Logan 5-aminosalicylic acids and the risk of renal disease a large British epidemiologic study Gastroenterology 126 2004 1733 1739
15. R.A. Marrie, C. Wolfson, M.C. Sturkenboom Multiple sclerosis and antecedent infections a case-control study Neurology 54 2000 2307 2310
16. M.A. Hernan, S.S. Jick, M.J. Olek, H. Jick Recombinant hepatitis B vaccine and the risk of multiple sclerosis a prospective study Neurology 63 2004 838 842
17. K.G. Becker, R.M. Simon, J.E. Bailey-Wilson Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases Proc Natl Acad Sci U S A 95 1998 9979 9984
18. I. Storch, D. Sachar, S. Katz Pulmonary manifestations of inflammatory bowel disease Inflamm Bowel Dis 9 2003 104 115
19. M.B. Casey, H.D. Tazelaar, J.L. Myers Noninfectious lung pathology in patients with Crohn's disease Am J Surg Pathol 27 2003 213 219
20. A. Ekbom, C.G. Helmick, M. Zack, L. Holmberg, H.O. Adami Survival and causes of death in patients with inflammatory bowel disease a population-based study Gastroenterology 103 1992 954 960
21. P.G. Persson, O. Bernell, C.E. Leijonmarck, B.Y. Farahmand, G. Hellers, A. Ahlbom Survival and cause-specific mortality in inflammatory bowel disease a population-based cohort study Gastroenterology 110 1996 1339 1345
22. K.V. Winther, T. Jess, E. Langholz, P. Munkholm, V. Binder Survival and cause-specific mortality in ulcerative colitis follow-up of a population-based cohort in Copenhagen County Gastroenterology 125 2003 1576 1582
23. E.H. Rang, B.N. Brooke, J. Hermon-Taylor Association of ulcerative colitis with multiple sclerosis Lancet 2 1982 4
24. K. Kimura, S.F. Hunter, M.S. Thollander Concurrence of inflammatory bowel disease and multiple sclerosis Mayo Clin Proc 75 2000 802 806
25. L.J. Edwards, C.S. Constantinescu A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic Multiple Sclerosis 10 2004 575 581
26. A. Geissler, T. Andus, M. Roth Focal white-matter lesions in brain of patients with inflammatory bowel disease Lancet 345 1995 897 898
27. F.A. Gondim, T.H. Brannagan III, H.W. Sander, R.L. Chin, N. Latov Peripheral neuropathy in patients with inflammatory bowel disease Brain 128 2005 867 879
28. N. Mohan, E.T. Edwards, T.R. Cupps Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides Arthritis Rheum 44 2001 2862 2869
29. R. Foroozan, L.M. Buono, R.C. Sergott, P.J. Savino Retrobulbar optic neuritis associated with infliximab Arch Ophthalmol 120 2002 985 987
30. S.A. Nanavati, G.A. Ergun, J.T. Schwartz Avoiding infliximab in the treatment of Crohn's disease in patients with multiple sclerosis Am J Gastroenterol 98 2003 2333 2334
31. M.P. ten Tusscher, P.J. Jacobs, M.J. Busch, L. de Graaf, W.L. Diemont Bilateral anterior toxic optic neuropathy and the use of infliximab (letter) BMJ 326 2003 579
32. L.J. Mejico Infliximab-associated retrobulbar optic neuritis Arch Ophthalmol 122 2004 793 794
33. B.Y. Strong, B.C. Erny, H. Herzenberg, K.J. Razzeca Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease (letter) Ann Intern Med 140 2004 W34
34. C.W. Thomas Jr, B.G. Weinshenker, W.J. Sandborn Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease Inflamm Bowel Dis 10 2004 28 31
35. The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group TNF neutralization in MS results of a randomized, placebo-controlled multicenter study Neurology 53 1999 457 465
36. B.K. Kleinschmidt-DeMasters, K.L. Tyler Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis N Engl J Med 353 2005 369 374
37. A. Langer-Gould, S.W. Atlas, A.J. Green, A.W. Bollen, D. Pelletier Progressive multifocal leukoencephalopathy in a patient treated with natalizumab N Engl J Med 353 2005 375 381
38. G. Van Assche, M. Van Ranst, R. Sciot Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N Engl J Med 353 2005 362 368